PPT-The Importance of Beta-Blockers in Patients with Heart Failure:

A R esynchronizationDefibrillation for A mbulatory Heart F ailure T rial RAFT Analysis L Brent Mitchell Jean L Rouleau Gary E Newton Jonathon Howlett Elizabeth . David W . Kabel. MD FACC. CHF-. Neurohormonal. Activation. NH activation is an acute adaptation that initially allows BP and cardiac output to be maintained. NH activation rapidly becomes detrimental. Tara Hosseinnejad, Brenda Rattanavong, Angela Y. assa. , Wai Ying Chan. Nov. 29. th. , 2016. PHM142 Fall 2016. Instructor: Dr. Jeffrey Henderson. Outline. Introduction of beta blockers. Non-selective (β. (Inderal, Inderal – LA generic). A CARDIOVASCULAR BETA BLOCKER. TEAM 2 MEMBERS:. . Stella . O. . Akpuaka. . . Bosede. . Adedire. Tamika Missouri. Amanda . Rothenbecker. What are Cardiovascular agents?. BA (Hons) RGN. Heart Failure Specialist Nurse. RGN BA (Hons). The very essence of cardiovascular practice is the early detection of heart failure. ’. Sir Thomas Lewis, 1933. Heart Failure Definition. A CARDIOVASCULAR BETA BLOCKER. TEAM 2 MEMBERS:. . Stella . O. . Akpuaka. . . Bosede. . Adedire. Tamika Missouri. Amanda . Rothenbecker. What are Cardiovascular agents?. Wide variety of drugs used for management and treatment of several different conditions of the heart and blood vessels.. adrenoceptor. blocking drugs. Beta-. adrenoceptor. blocking drugs (beta-blockers) block the beta-. adrenoceptors. in the heart, peripheral vasculature, bronchi, pancreas, and liver.. Intrinsic sympathomimetic activity . Dr.AZDAKI. . (cardiologist).  Initial . monotherapy. is successful in many patients with mild primary hypertension (formerly called "essential" hypertension). . However, single-drug therapy is unlikely to attain goal blood pressure in patients whose blood pressures are more than 20/10 mmHg above goal. . Assist. . Lec. . . Sura. . abbas. . Assist. . Lec. . . Lubab. . tareq. Adverse effects of BB. Beta blockers are generally well tolerated and most adverse effects are mild and transient. . Reactions may be more severe after intravenous than oral doses;. Lec. . . Sura. . abbas. . Medicine ward. Quick revision. The most common causes of heart failure are coronary artery disease (CAD), hypertension, and dilated cardiomyopathy. . The sympathetic nervous system and the renin-angiotensin. Update 2 Report Date: May 2005 topic is done periodically The purpose of this report is to mcomparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are 1 Beta - blockers have been widely used in the management of angina, certain tachyarrhythmias and heart failure, as well as in hypertension . Examples Acebutolol Atenolol Bisoprolol Carvedilol Celip Vol. 25, No. 6 1327 May 1995:1327-32 With Beta-Adrenergic Blocking Agents After Myocardial Infarction: From Randomized Trials to Clinical Practice VISKIN, MD,* ILAN KITZIS, MD,? ELI LEV, MD, ZEEV ZA Introduction Beta blockers have a long and well - established history of use for a variety of indications, and are one of the most widely used pharmacological agents for patients with cardiovascular An individual patient level analysis of double-blind randomised trials. Dipak Kotecha, MBChB PhD MRCP FESC FHEA. on behalf of the . . Beta-blockers in Heart Failure Collaborative Group. Douglas Altman.